RGLS REGULUS THERAPEUTICS INC Management Changes 8-K Filing 2024 - Annual Meeting of Stockholders Regulus Therapeutics Inc. held its Annual Meeting of Stockholders on May 16, 2024, where the stockholders approved an amendment to the 2019 Equity Incentive Plan and elected directors. The company also received approval for the selection of Ernst & Young LLP as its independent registered public accounting firm and the compensation of its named executive officers.Get access to all SEC 8-K filings of the REGULUS THERAPEUTICS INC